We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.53B
AUM Growth
+$98M
Cap. Flow
-$58.3M
Cap. Flow %
-1.65%
Top 10 Hldgs %
13.53%
Holding
1,397
New
118
Increased
442
Reduced
608
Closed
107

Sector Composition

Rank Sector Weight
1 Healthcare 12.97%
2 Financials 11.54%
3 Technology 10.61%
4 Industrials 9.38%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMG icon
1126
Affiliated Managers Group
AMG
$9.72B
$220K 0.01%
+1,342
New +$212K
EMB icon
1127
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$220K 0.01%
1,938
-83
-4% -$9.35K
WTM icon
1128
White Mountains Insurance
WTM
$5.21B
$220K 0.01%
250
-50
-17% -$44.8K
IXP icon
1129
iShares Global Comm Services ETF
IXP
$524M
$219K 0.01%
3,675
-309
-8% -$18.4K
QRVO icon
1130
Qorvo
QRVO
$7.93B
$219K 0.01%
+3,188
New +$205K
SIOX
1131
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$219K 0.01%
+1,834
New +$192K
FPA icon
1132
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$102M
$218K 0.01%
+7,000
New +$208K
JBL icon
1133
Jabil
JBL
$32.8B
$218K 0.01%
+7,546
New +$193K
JPM.WS
1134
DELISTED
JPMorgan Chase
JPM.WS
$218K 0.01%
4,710
-528
-10% -$24.6K
FBT icon
1135
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.77B
$217K 0.01%
2,061
-2,958
-59% -$296K
PSK icon
1136
State Street SPDR ICE Preferred Securities ETF
PSK
$691M
$217K 0.01%
4,941
-587
-11% -$25.6K
HMSY
1137
DELISTED
HMS Holdings Corp.
HMSY
$217K 0.01%
10,667
-10,459
-50% -$193K
NFO
1138
DELISTED
Invesco Insider Sentiment ETF
NFO
$217K 0.01%
+4,075
New +$210K
LDOS icon
1139
Leidos
LDOS
$14.2B
$216K 0.01%
4,215
-1,200
-22% -$61.8K
GBF icon
1140
iShares Government/Credit Bond ETF
GBF
$133M
$215K 0.01%
1,908
+13
+0.7% +$1.46K
VDC icon
1141
Vanguard Consumer Staples ETF
VDC
$7.98B
$215K 0.01%
1,529
-570
-27% -$79K
BSJM
1142
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
$215K 0.01%
+8,496
New +$214K
BBN icon
1143
BlackRock Taxable Municipal Bond Trust
BBN
$978M
$214K 0.01%
9,567
+66
+0.7% +$1.46K
BSJI
1144
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
$214K 0.01%
+8,437
New +$213K
CPRI icon
1145
Capri Holdings
CPRI
$1.82B
$213K 0.01%
5,600
-500
-8% -$19.7K
FIT
1146
DELISTED
Fitbit, Inc. Class A common stock
FIT
$213K 0.01%
35,913
+5,550
+18% +$35.2K
FTHI icon
1147
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.38B
$212K 0.01%
9,994
SPIB icon
1148
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$212K 0.01%
+6,198
New +$211K
NTNX icon
1149
Nutanix
NTNX
$15.9B
$211K 0.01%
+11,234
New +$302K
ELS icon
1150
Equity Lifestyle Properties
ELS
$12.7B
$210K 0.01%
+5,448
New +$206K

Similar funds

Oppenheimer & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Oppenheimer & Co held 1,397 positions worth $3.53B, up 2.9% from $3.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q1 2017 filing shows 118 new, 442 increased, 608 reduced and 107 closed positions. Its largest new stake was Robert Half: 53,601 shares worth $2.62M. The largest sale was Finish Line, an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q1 2017 buy was Robert Half: 53,601 shares worth $2.62M.
  • Oppenheimer & Co added most to Enbridge in Q1 2017, an estimated $9.97M increase.
  • Oppenheimer & Co's biggest Q1 2017 reduction was Finish Line, cutting an estimated $14.5M.
  • Oppenheimer & Co fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $9.83M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.53B portfolio in Q1 2017.
  • Oppenheimer & Co opened 118 new positions and closed 107 in Q1 2017.
  • Oppenheimer & Co's portfolio value rose 2.9% quarter-over-quarter to $3.53B.

Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.